date,title,source
Oct-23-18,KemPharm and twoXAR Announce Technology Collaboration to Develop Prodrug-Based Therapies for Multiple Indications,GlobeNewswire
Oct-24-18,KemPharm Presents Data from Intranasal and Intravenous Human Abuse Potential Trials of KP415 Prodrug at the American Academy of Child & Adolescent Psychiatry Meeting,GlobeNewswire
Nov-01-18,KemPharm to Report Third Quarter 2018 Results,GlobeNewswire
Nov-08-18,"KemPharm, Inc. Reports Third Quarter 2018 Results",GlobeNewswire
Nov-09-18,Edited Transcript of KMPH earnings conference call or presentation 8-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-13-18,"KemPharm Enhances Pipeline with the Addition of KP879, a Potential New Treatment for Stimulant Use Disorder",GlobeNewswire
Nov-19-18,Edited Transcript of KMPH earnings conference call or presentation 8-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-20-18,Edited Transcript of KMPH earnings conference call or presentation 8-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-21-18,"Analysis: Positioning to Benefit within KemPharm, Bellerophon Therapeutics, Exela Technologies, Intec Pharma, Cerecor, and Chiasma  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Nov-26-18,What Kind Of Shareholders Own KemPharm Inc (NASDAQ:KMPH)?,Simply Wall St.
Dec-03-18,KemPharm to Webcast Live at VirtualInvestorConferences.com on December 6th,PR Newswire
Dec-04-18,"Live Investor Conference & Webinar: NYSE, NASDAQ, and OTC companies present December 6th",PR Newswire
Dec-11-18,KemPharm Webcast on VirtualInvestorConferences.com Now Available for On-Demand Viewing,PR Newswire
